• Thursday, Oct 01, 2020
  • Last Update : 08:58 pm

India's Wockhardt strikes deal to supply Covid-19 vaccines to UK

  • Published at 05:41 pm August 3rd, 2020
Coronavirus Vaccine
File photo: A small bottle labeled with a 'Vaccine' sticker is held near a medical syringe in front of displayed 'Coronavirus Covid-19' words in this illustration taken on April 10, 2020 Reuters

This is the latest step by the UK to secure supplies and production of Covid-19 vaccines after striking four deals with drug makers to buy their potential shots

Indian drug maker Wockhardt Ltd will supply millions of doses of multiple Covid-19 vaccines, including that being developed by AstraZeneca and Oxford University, under a deal with the UK government announced on Monday.

Shares of Wockhardt jumped 10% after the news in a downcast Mumbai market.

The company has reserved fill-and-finish capacity - the final manufacturing step of putting vaccines into vials or syringes and packaging them - as part of the agreement, it said.

This is the latest step by the UK to secure supplies and production of Covid-19 vaccines after striking four deals with drug makers to buy their potential shots.

"Fill finish is a critical step in the process to get the vaccine in a form to be given to patients. The agreement with Wockhardt will boost our capability to ensure that," Kate Bingham, chair of UK Vaccines Task Force, said in a statement.

The UK government has also reserved one fill-and-finish production line at a Wockhardt subsidiary in Wrexham, Wales for its exclusive use for the next 18 months to secure supply. It is expected to start the Wexham line in September.

AstraZeneca has indicated it would need 30 million fill-and-finish doses of their vaccine candidate, which the company intends to supply in the next few months, Wockhardt Chairman Habil Khorakiwala said during a virtual press briefing.

The company has a fill-and-finish manufacturing capacity of 400 million doses in the UK and 600 million in India, for a combined capacity of 1 billion, Khorakiwala said.

More than 150 vaccines are being developed and tested around the world to stop the pandemic, with 26 in human clinical trials, according to the World Health Organization.

AstraZeneca and Oxford University's vaccine candidate is seen as one of the frontrunners in the race to fight the pandemic.

51
50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail